Lab
Thousand Oaks Pathology Associates INC
Thousand Oaks Pathology Associates INC was paid $5.04M by Medicaid between Jan 2018 and Nov 2024, across 33 billing codes. Its largest line is 87633, Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets — 54% of everything it billed.
33Billing provider infoTHOUSAND OAKS PATHOLOGY ASSOCIATES INC
THOUSAND OAKS, CA 91361
THOUSAND OAKS, CA 91361
33aNPI1912930900assigned 07/10/2006
33bProvider typeClinical Medical Laboratory
28Total paid$5.04M
24GClaims58,108
24DCodes billed33
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in California
Rank by total paid#106 of 561
Median peer was paid$222K
This provider vs. median23×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,795 | $176K | |
| 2019 | 4,636 | $384K | |
| 2020 | 6,146 | $524K | |
| 2021 | 11,454 | $950K | |
| 2022 | 13,786 | $1.24M | |
| 2023 | 12,195 | $1.14M | |
| 2024incomplete | 8,096 | $631K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 54% | 6,346 | 6,231 | $2.72M |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 10% | 6,860 | 6,622 | $526K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 6.2% | 11,332 | 10,321 | $311K |
| 87486 | 4.6% | 6,398 | 6,282 | $234K | |
| 87581 | 4.6% | 6,394 | 6,278 | $233K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.4% | 2,449 | 2,279 | $172K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 2.6% | 367 | 364 | $129K |
| 88312 | 2.1% | 2,099 | 1,872 | $108K | |
| 87481 | 2.1% | 1,097 | 1,028 | $106K | |
| 88341 | 1.3% | 1,093 | 1,039 | $65K | |
| 88173 | 1.2% | 2,218 | 1,956 | $62K | |
| 88304 | 1.0% | 1,471 | 1,351 | $51K |
21 more codes
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,376 | $46K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,364 | $46K |
| 87511 | <1% | 1,027 | $38K | |
| 88360 | <1% | 741 | $34K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 928 | $33K |
| 88342 | <1% | 1,510 | $29K | |
| 87631 | <1% | 306 | $22K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 238 | $14K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 556 | $13K |
| 87507 | <1% | 28 | $12K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 636 | $10K |
| 87505 | <1% | 44 | $6K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 697 | $4K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 36 | $3K |
| 88313 | <1% | 38 | $2K | |
| 87510 | <1% | 92 | $2K | |
| 87480 | <1% | 92 | $2K | |
| 87660 | <1% | 92 | $2K | |
| 88374 | <1% | 143 | $1K | |
| 87150 | <1% | 26 | $539.24 | |
| 87081 | <1% | 14 | $71.54 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHULTHEIS, WAYNE (PATHOLOGIST/MANAGING PARTNER)
| Provider | Location | Paid |
|---|---|---|
| Glover, Kelty & Schultheis MDS | Thousand Oaks, CA | $781K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.